NCT06715956View on ClinicalTrials.gov

Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

January 1, 2027

Conditions
Non-cystic Fibrosis Bronchiectasis (NCFBE)
Interventions
OTHER

Observational Cohort Classification of Inflammatory Subtypes in Bronchiectasis

This observational study classifies patients with non-cystic fibrosis bronchiectasis into inflammatory subtypes based on sputum analysis. No active treatment or intervention is administered during this observational phase. Participants will later be considered for treatment with HSK31858 as part of an independent clinical trial.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT06715956 - Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis | Biotech Hunter | Biotech Hunter